Background: Apolipoprotein B (apo B) has been reported to be a better predictor of coronary artery disease than cholesterol indices. The objectives of this study were to evaluate concordances/discordances between cholesterol indices and apo B and to assess the factors that influence them. Methods: For this study, 11 816 individuals (6965 males, 4851 females), none of whom had a past history of coronary artery disease, were selected from among visitors to the health promotion center at Kangbuk Samsung Hospital between January and December 2002. We assessed concordances between the biochemical indices of atherogenicity and evaluated factors associated with discordances. Results: Apo B and various cholesterol indices were correlated, although concordance fell within the range 47%-56%. Multinomial logistic regression analysis showed an increasing risk of a disproportionately higher apo B than LDL-cholesterol in males, the elderly, smokers, individuals with metabolic syndrome, in those with high HDL-cholesterol or triglyceride (TG) concentrations or larger waist circumferences, and in those with low total cholesterol (TC). Conclusions: The introduction of apo B to standard lipid profile testing could improve the evaluation of risk factors of coronary artery disease and aid more accurate assessment of the effects of cholesterol-lowering therapy, particularly in males, the elderly, smokers, or in individuals with metabolic syndrome, high HDL-cholesterol, high TGs, larger waist circumferences, or low TC.
1 is one of the primary factors of coronary artery disease, and the lowering of serum LDL-C concentrations considered a primary therapeutic goal (1 ) . Non-HDL-cholesterol (non-HDL-C) was considered as a possible target for replacement of apolipoprotein B (apo B), particularly for persons suffering from hypertriglyceridemia [2. 26 mmol/L (200 mg/dL) Յ triglycerides Ͻ 5.65 mmol/L (500 mg/dL)], in view of the known strong relationship between non-HDL-C and apo B in serum (1 ) . Recently, many studies have focused on issues other than LDL because it has also been reported that VLDL, intermediate-density lipoproteins, HDL, and apolipoproteins exert influences on atherosclerosis, perhaps to extents similar to that of LDL (2 ) . In addition, some studies have concluded that serum apo B and apo B/A 1 ratio are likely to be more effective at predicting the risk of coronary artery disease and consequently emphasized the importance of apolipoprotein as a surrogate for summation of atherogenic entities (2) (3) (4) (5) (6) (7) (8) .
The objectives of the present study were to evaluate the concordance and association of serum LDL-C and the various other cholesterol indices with serum apolipoprotein and to assess those factors associated with concordance/discordance between serum LDL-C and apo B.
Materials and Methods materials methods
Interviews were conducted with all study participants to determine whether they had any history of diabetes or hypertension or a family history of coronary artery disease, and to document other relevant variables, i.e., smoking habits and body mass indices. Individuals were classified as having hypertension if the following conditions were satisfied: a previous history of hypertension, current use of antihypertensive agents, and a systolic blood pressure Ն140 mmHg or a diastolic blood pressure Ն90 mmHg, in accordance with the standard guidelines issued by the Joint National Committee on the Classification of Blood Pressure (JNC-VII) (9 ) . Individuals were deemed to have diabetes if they had received a previous diagnosis of diabetes, were receiving diabetes therapy, or if they had a blood glucose Ն6.99 mmol/L (126 mg/dL) after a 12-h fast, in accordance with the guidelines of the American Diabetes Association (10 ) . Metabolic syndrome was defined using the World Health Organization-West Pacific Region guidelines (11 ) when 3 or more of the following conditions were present: (a) abdominal obesity (waist circumference Ͼ90 cm for men, Ͼ80 cm for women); (b) triglyceride (TG) concentration Ն1.70 mmol/L (150 mg/ dL); (c) HDL-C Ͻ1.04 mmol/L (40 mg/dL) for men or Ͻ1.3 mmol/L (50 mg/dL) for women; (d) systolic/diastolic blood pressure Ն130/85 mmHg; and (e) fasting glucose Ն6.11 mmol/L (110 mg/dL). The blood samples for testing were drawn after a participants had fasted for 12 h. Total cholesterol (TC) and TG concentrations in serum were measured by an enzymatic calorimetric test (Bayer Diagnostics), and serum HDL-C concentrations were measured by a selective inhibition technique (Bayer Diagnostics). LDL-C was determined by a homogeneous enzymatic colorimetric test (Hitachi 747; Hitachi), and apo B and apo A 1 concentrations were determined by rate nephelometry (IMMAGE system; Beckman Coulter). Blood pressure was measured with a standard sphygmomanometer after examinees had relaxed for at least 5 min (12 ) . Heights and weights were measured by automatic instruments, and body mass index (kg/m 2 ) was calculated in the usual manner.
statistical analysis
All statistical analyses were conducted with SPSS for Windows (Ver. 1.10). All results are reported as the mean (SD), and Pearson correlation coefficients were applied to evaluate correlations among variables. Concordance/discordance was evaluated by dividing a variable into quintile groups. Concordance was defined when 2 variables existed within the same quintile, and discordance when this was not the case. We used k statistics to determine the degree of agreement between 2 related variables. To compare clinical variables derived from concordant/discordant LDL-C and apo B clusters, discordant clusters in which LDL-C values were higher than apo B values were designated group I, and when LDL-C values were lower than apo B values, they were designated as group II. Concordant clusters were designated as group III. Comparisons of variables among groups I, II, and III were performed with one-way ANOVA and the 2 test. Odds ratios for all individuals were analyzed via multinomial 
Results
The characteristics of the examined population are presented in Table 1 . The data showed that women had significantly higher age, HDL-C, and apo A 1 than men and that men had significantly higher values for all remaining variables (Table 1) . After adjusting for age, blood pressure, body mass index, waist circumference, fasting blood glucose, diabetes, smoking habits, and metabolic syndrome, we found that males had higher TC, apo B, and apo B/A1 and that females had higher HDL-C. Correlation analyses of cholesterol indices and apolipoprotein revealed that apo B was strongly correlated with LDL-C and non-HDL-C (r ϭ 0.734 and 0.830, respectively; Table 2 ).
Concordance/discordance analyses for LDL-C and apo B indicated an overall concordance of 47.6% and concordances of 47.1% for males and 48.4% for females, respectively. Moreover, the lowest and highest quintile groups showed a higher degree of overall concordance than the other groups (Ͼ60%: 33%-40%). The overall concordance between non-HDL-C and apo B was 56.2%, and the overall concordance between TC/HDL-C and apo B/A 1 was 53.9%. However, we found discordances between cholesterol indices and apo B in more than one third of the study participants (Table 3) .
Cholesterol indices and apolipoprotein concentrations showed fair and moderate agreement. Moreover, the highest agreement (k ϭ 0.45) between these variables was between non-HDL-C and apo B (Table 4) . Our analysis of differences between variables in groups I, II, and III indicated that group II, in which apo B was disproportionately higher than LDL-C, contained a greater proportion of elderly, males, hypertensive or diabetic persons, individuals with metabolic syndrome, and individuals with a history of smoking. Group II also had significantly higher TG and non-HDL-C concentrations, apo B/A 1 ratios, fasting blood glucose concentrations, blood pressure, body mass indices, and waist circumferences and lower TC and LDL-C concentrations than groups I and III (Table 5) .
Multinomial logistic regression analyses of factors affecting concordance/discordance between apo B and LDL-C revealed that group II contained a larger proportion of males, elderly, smokers, and individuals with metabolic syndrome, a larger waist circumference, high TG and HDL-C, and low TC than the concordant group. Group I, in which LDL-C concentrations were disproportionately higher than apo B, contained a markedly lower proportion of males, smokers, and persons with diabetes and a substantially larger proportion of individuals with high TC and low HDL-C concentrations than the concordant group (Figs. 1 and 2 ).
Discussion
In this investigation, we attempted to determine concordances and correlations between serum LDL-C and various cholesterol indices, and serum apolipoproteins. Our results indicate that there are strong correlations between various cholesterol indices and LDL-C and apo B. However, these correlations were associated with fairly low concordance. In particular, group II, in which apo B concentrations were disproportionately higher than a All values except for those indicated by "n (%)" are the mean (SD). b Group I refers to persons belonging to an LDL-C quintile higher than the corresponding apo B quintile; group II refers to persons belonging to an apo B quintile higher than the corresponding LDL-C quintile; group III refers to persons with concordance between apo B and LDL-C. c 2 for linear trend: P Ͻ0.001. d Significantly different (P Ͻ0.05) for group I vs group II or III. e Significantly different (P Ͻ0.05) for group II vs group III by Student-Newman-Keuls post hoc analysis. f BP, blood pressure; MS (ϩ), metabolic syndrome present.
LDL-C concentrations, exhibited higher odds ratios for males, the elderly, smokers, individuals with metabolic syndrome, those with large waist circumferences, those with high TG and HDL-C concentrations, and those with low TC concentrations than for the concordant group. Smoking status was the strongest predictor of disproportionately high apo B between the concordant group (group III) and the disproportionately high apo B group (group II) in all study participants. In addition, for group I, in which LDL-C concentrations were disproportionately higher than apo B concentrations, odds ratios were higher for females, nonsmokers, nondiabetic persons, and individuals with a high TC and a low HDL-C than in the concordant group.
Recent studies have indicated that LDL concentrations vary widely in individuals with high TGs, with regard to both the numbers and sizes of LDL particles, and that this measurement is not appropriate as a substitute for total lipoprotein. Apolipoproteins are known to determine the structural stabilities and metabolic directions of lipoproteins. Of the apolipoproteins, apo B has been identified in VLDL, intermediate-density lipoprotein, and LDL particles and thus appears to be a measure of the total number of atherogenic particles (13, 14 ) . Sniderman et al. (15 ) suggested that small, dense LDL particles are more atherogenic than larger, buoyant LDL and that apo B is a more accurate measure than LDL-C with regard to predicting the development of coronary artery disease in patients with type 2 diabetes in addition to hypertriglyceridemia and hyperapolipoproteinemia B.
In this investigation, we found that apo B was strongly correlated with LDL-C (r ϭ 0.734) and non-HDL-C (r ϭ 0.83). This result is consistent with those of previous studies (16 -18 ) . However, the findings of the Quebec cardiovascular study conducted by Sniderman et al. (18 ) , in which 2103 males were enrolled and which investigated concordances between apo B and various cholesterol indices, suggested that apo B is strongly correlated with LDL-C (r ϭ 0.78), although this agreement was only fair (k ϭ 0.36). Thus, the authors proposed that plasma apo B and the various cholesterol indices represent complementary rather than redundant atherosclerotic risk indices, thereby providing further evidence for including apo B measurement as a component of the standard lipoprotein measurements performed to assess cardiovascular disease risk (18 ) . These differences in statistical factors, such as correlation coefficient and k statistics, demonstrate that the correlation analysis indicates the degree of linear correlations between 2 variables but does not provide information on the dispersion of values (19 ) . The findings of the present study are consistent with the results obtained by Sniderman et al. (r ϭ 0.734; k ϭ 0.35) (15 ) . We also found that the correlation coefficient and overall concordance rate between non-HDL-C and apo B were slightly higher than those between LDL-C and apo B, but the results of multinomial logistic regression analysis of factors affecting concordance/discordance between non-HDL-C and apo B were similar to those between LDL-C and apo B.
The findings of the present study indicate that, according to the cholesterol-lowering therapy guidelines issued by the National Cholesterol Education Program ATP III, the persons in group II, in which apo B was disproportionately higher than LDL-C, could be excluded from a cholesterol-lowering therapy. In particular, the odds ratios of disproportionately high apo-B were 2.1 for smokers and 1.4 for males. Smoking has been reported to perturb TG metabolism and to increase serum TG concentrations (20, 21 ) . Furthermore, the sizes of LDL particles are intimately related to both serum TG and HDL concentrations (22, 23 ) . Moreover, Griffin et al. (23 ) previously reported that a smoking group exhibited a lower large-to-small LDL ratio than a nonsmoking group. However, this difference between the 2 groups was abolished by correcting for TG concentrations (23 ) . In our study, the risk of disproportionately high apo B was high in smokers, even after adjusting for TG concentrations. We are unable to clearly explain this result because our investigation did not include LDL subfraction measurements.
Sex is reportedly a factor that influences small, dense LDL particles (24, 25 ) . Nikkila et al. (25 ) reported that larger and less atherogenic LDL particles were observed in women and suggested that this may be attributable to lower hepatic lipase activity resulting from the influence of female sex hormones. In our study, we found that the risk of a disproportionately higher apo B than LDL-C was higher in males than in females. This might be attributable to the fact that males have smaller, denser LDL particles than females.
Some limitations are inherent in this study. First, it is a cross-sectional study and therefore cannot predict the development of coronary artery disease, nor can it predict the effects of cholesterol-lowering therapy in the concordance and discordance groups. Second, this study did not use accurate examinations for diabetes, i.e., oral glucose tolerance testing. Third, the study may show participant selection bias. However, the study is meaningful in terms of the correlation and concordance between apo B and the other cholesterol indices in a large number of individuals.
In conclusion, the results of this study suggest that the inclusion of apo B measurements as a component of the total atherogenic potential index within the standard lipid profile test might allow more accurate evaluation of the risk factors of coronary artery disease and more accurate assessment the effects of cholesterol-lowering therapies. However, further prospective studies regarding the development and prognosis of cardiovascular diseases, and of the effects of cholesterol-lowering therapy based on apo B and LDL-C concentrations, should be performed to further enhance our knowledge of these issues.
